Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired (Tables)

v3.21.2
Licenses Acquired (Tables)
6 Months Ended
Jun. 30, 2021
Licenses Acquired  
Schedule of Research and Development-Licenses

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended June 30, 

​

Six Months Ended June 30, 

($ in thousands)

    

2021

    

2020

    

2021

    

2020

Partner companies:

 

​

  

 

​

  

 

​

  

 

​

  

JMC

​

$

10,000

​

$

—

​

$

10,000

​

$

—

Mustang

​

​

1,000

​

​

1,300

​

​

1,000

​

​

1,550

Aevitas

​

​

2

​

​

—

​

​

27

​

​

—

Oncogenuity

​

​

1

​

​

270

​

​

1

​

​

270

FBIO Acquisition Corp VIII

​

​

—

​

​

—

​

​

101

​

​

—

Total

​

$

11,003

​

$

1,570

​

$

11,129

​

$

1,820

Schedule of Research and Development for Licenses Acquired

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended June 30, 

​

For the Six Months Ended June 30, 

($ in thousands)

    

2021

    

2020

    

2021

    

2020

City of Hope National Medical Center

​

​

​

​

​

​

​

​

​

​

​

​

CD123 (MB-102)

​

​

250

​

​

334

​

​

250

​

​

334

IL13Rα2 (MB-101)

​

$

—

​

$

333

​

$

—

​

$

333

HER2 (MB-103)

​

​

—

​

​

—

​

​

—

​

​

250

PSCA (MB-105)

​

​

—

​

​

333

​

 

—

​

 

333

Mayo Clinic

​

​

750

​

​

​

​

​

750

​

​

—

Fred Hutchinson Cancer Research Center - CD20 (MB-106)

​

​

—

​

​

300

​

​

—

​

​

300

Total

​

$

1,000

​

$

1,300

​

$

1,000

​

$

1,550